Intrapleural Bevacizumab Injection for Malignant Effusion in Lung Cancer

Clinical trial NCT02054052 · COMPLETED

Trial details

NCT number: NCT02054052
Sponsor: Haihong Yang, MD, Pricipal investigator
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer Malignant Pleural Effusion

Start date: 2014-01-01
Primary completion: 2019-03-01
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.